8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE(302788-80-3)
- Name: 8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE
- Synonyms:8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE;8-PHENYL-4,5-DIHYDRO[1,2,5]OXADIAZOLO[3,4-F]CINNOLINE
- Molecular Formula:C14H10 N4 O
- Molecular Weight:250.26
- CAS Registry Number:302788-80-3
- EINECS:
- Melting Point:208 °C
- Water Solubility:
CAS No.302788-80-3 8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.302788-80-3 [1,2,5]Oxadiazolo[3,4-f]cinnoline,4,5-dihydro-8-phenyl-
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)] CAS No.302788-80-3 8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.302788-80-3 8-phenyl-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnoline
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 302842-60-0/1,3,4-Oxadiazol-2-amine,5-(methoxymethyl)-(9CI)
- 392312-40-2/5-Isoxazolemethanamine,N,N-diethyl-3-methyl-(9CI)
- 302838-25-1/1H-Indene-2-carboxylicacid,1-amino-2,3-dihydro-5-hydroxy-(9CI)
- 302825-76-9/(R)-Verapamilic Acid (S)-α-Methylbenzylamine Salt
- 302818-58-2/1,2,4-Triazolo[4,3-b][1,2,4]triazin-3-amine(9CI)
- 392312-36-6/1H-Pyrrole-1-ethanamine,2-methyl-(9CI)
- 302812-79-9/2H-Benzimidazole-2-thione,5-ethoxy-1,3-dihydro-1-methyl-(9CI)
- 302804-66-6/3-[(4-METHYLBENZYL)THIO]-1H-1,2,4-TRIAZOLE
- 302802-22-8/1,2,5-Oxadiazole-3-carboxylicacid,4-amino-,2-hydroxyethylester(9CI)
- 392312-34-4/1,3-Benzenediol, 4-[(2-pyrimidinylimino)methyl]- (9CI)
- 302800-65-3/[1,2,5]Oxadiazolo[3,4-d]pyrimidine,7-ethoxy-5-methoxy-,1-oxide(9CI)
- 302800-26-6/1,2-Pentanediamine,N1,N1,4-trimethyl-,(2S)-(9CI)
- 302798-54-5/(LEU31,PRO34)-NEUROPEPTIDE Y (13-36) (HUMAN, RAT)
- 302797-24-6/4-Pentene-2,3-dione, 4-methoxy- (9CI)
- 392300-29-7/1,2,3-Cyclohexanetriol, 2-(2-propenyl)-, 1-acetate, (1S,2R,3R)- (9CI)
- 302796-65-2/1,2,5-Oxadiazole-3-carboxamide,4-amino-N-hydroxy-(9CI)
- 302791-95-3/HDI/PPG/POLYCAPROLACTONE CROSSPOLYMER
- 302790-90-5/Pyrrolo[1,2-a]pyrazine-1,4-dione, hexahydro-3-hydroxy-3-methyl-, (8aS)- (9CI)
- 392249-81-9/1H-Imidazo[4,5-d]pyridazine-4,7-dione, 5,6-dihydro-5,6-dimethyl-
- 302788-80-3/8,9-DIHYDRO-3-PHENYL-1,2,5-OXADIAZOLO[3,4-F]CINNOLINE
- 302785-50-8/3-(1-METHYL-3-PHENYL-PROPYLAMINO)-PROPIONITRILE
- 302780-17-2/Bicyclo[2.2.1]heptane-2-carbonitrile, 3,6-dimethyl- (9CI)
- 302778-34-3/Cyclopropaneacetonitrile, 3-cyano-2,2-dimethyl- (9CI)
- 302778-29-6/Morpholine, 4-[[(2R)-3,3-dimethyloxiranyl]methyl]- (9CI)
- 302776-79-0/8aH-Pyrrolo[3,2-e]-2,1,3-benzoxadiazol-8a-ol,5a-amino-4,5,5a,8-tetrahydro-7-methyl-,3,6-dioxide,(5aR,8aR)-rel-(9CI)
- 392244-44-9/4-chloro-N-(5-methyl-1,3,4-thiadiazol-2-yl)butanamide
- 392244-43-8/2-Thiophenecarboxylicacid,3-[(2-furanylcarbonyl)amino]-4,5-dihydro-,methyl
- 302604-98-4/9-METHYL-4,5-DIHYDRO[1,2,5]OXADIAZOLO[3,4-F]CINNOLINE
- 302602-94-4/2-(2-PHENYL-IMIDAZOLE-1-CARBONYL)-BENZOIC ACID
- 392242-85-2/2-Thiophenecarboxylicacid,3-(acetylamino)-4,5-dihydro-,methylester(9CI)